FDA Clearance Tracker · P200035-S003
OrganOx metra System
Last checked: Nov 20, 2026Latest source record: Jul 7, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Jul 7, 2022
Approved
Time to decision
30 days
Received Jun 7, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P200035-S003
- Device name
- OrganOx metra System
- Applicant
- Organox Limited
- Applicant location
- Oxford
- Received
- Jun 7, 2022
- Decided
- Jul 7, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P200035
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval studies (PAS) protocol.
Source documents
Other decisions for Organox Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P200035 · Decided Dec 9, 2021 · 512 days after receipt
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.